1. Extremophilic orgainisms as and unexplored source fo antifungal compounds.
- Author
-
Phoebe CH Jr, Combie J, Albert FG, Van Tran K, Cabrera J, Correira HJ, Guo Y, Lindermuth J, Rauert N, Galbraith W, and Selitrennikoff CP
- Subjects
- Candida albicans drug effects, Chitin Synthase antagonists & inhibitors, Chromatography, High Pressure Liquid, Drug Evaluation, Preclinical methods, Enzyme Inhibitors pharmacology, Fermentation, Glucosyltransferases antagonists & inhibitors, Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing) antagonists & inhibitors, Microbial Sensitivity Tests, Phenols analysis, Phenols pharmacology, Antifungal Agents metabolism, Antifungal Agents pharmacology, Membrane Proteins, Schizosaccharomyces pombe Proteins, Thiazoles
- Abstract
Extracts of the biomasses and fermentation broths of 217 extremophilic microorganisms isolated from a number of locales were screened for antifungal activity using whole-cell and mechanism-based in vitro assays. Importantly, eleven broth extracts had activity against several Candida species and Aspergillus fumigatus in whole-cell in vitro assays. One broth specifically inhibited (1,3)beta-glucan synthase activity and four specifically inhibited ketol-isomerase activity, suggesting a mode of action of the antifungal compound(s) present in these extracts. The extract from one thermophile, a novel species of Pseudomonas, was fractionated, an active compound purified and its structure determined. The compound was identified as pyochelin, a previously identified iron-binding compound with heretofore undescribed antifungal activity. To our knowledge, this is the first report demonstrating that extremophiles synthesize compounds that have antifungal activity.
- Published
- 2001
- Full Text
- View/download PDF